GENE ONLINE|News &
Opinion
Blog

2022-04-15| In-Depth

New Approaches to Effectively Manage Hemophilia in Pregnant Women

by Arvind C. Shekhar
Share To
Hemophilia is a X-linked hereditary bleeding disorder characterized by an absent or decreased coagulation factor VIII (FVIII) in Hemophilia A (HA) or factor IX (FIX) in the case of Hemophilia B (HB). Caused due to a recessive X-chromosomal inheritance pattern, mostly men are affected while their female relatives generally serve as carriers of hemophilia. In terms of numbers, the prevalence of hemophilia is approximately 1 in 5000 males.

It's free! Log in now to read

LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top